Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership29,117 shares
Latest Disclosed Value $ 658,044
Citigroup Inc ownership in PCRX / Pacira BioSciences, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 29,117 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $658,044 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 34,942 shares of Pacira BioSciences, Inc.. This represents a change in shares of -16.67% during the quarter. The current value of the position is $649,891 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (PCRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PCRX / Pacira BioSciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 29,117 -5,825 -16.67 658 -27.21 0.0001
2026-02-13 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 34,942 4,147 13.47 904 14.00 0.0004
2025-11-10 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 30,795 -21,637 -41.27 794 -36.71 0.0004
2025-08-11 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 52,432 -32,504 -38.27 1,253 -40.62 0.0006
2025-05-12 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 84,936 7,377 9.51 2,111 44.42 0.0011
2025-02-12 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 77,559 -13,030 -14.38 1,461 7.19 0.0009
2024-11-12 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 90,589 48,786 116.70 1,363 14.06 0.0008
2024-08-12 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 41,803 3,780 9.94 1,196 7.56 0.0008
2024-05-10 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 38,023 -1,096 -2.80 1,111 -15.77 0.0007
2024-02-09 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 39,119 -14,042 -26.41 1,320 -19.08 0.0009
2023-12-06 2023-09-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 53,161 9,668 22.23 1,631 -6.43 0.0012
2023-11-09 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 53,161 9,668 1,631 0.0005
2023-08-10 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 43,493 15,301 54.27 1,743 51.48 0.0011
2023-05-11 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 28,192 -4,469 -13.68 1,151 -8.80 0.0008
2023-02-09 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 32,661 3,541 12.16 1,261 -18.59 0.0010
2022-11-10 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 29,120 639 2.24 1,549 -6.74 0.0011
2022-08-10 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 28,481 -21,121 -42.58 1,661 -56.13 0.0012
2022-05-12 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 49,602 4,878 10.91 3,786 40.69 0.0023
2022-02-10 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 44,724 -15,296 -25.48 2,691 -19.93 0.0014
2021-11-10 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 60,020 10,270 20.64 3,361 11.37 0.0020
2021-08-10 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 49,750 23,995 93.17 3,018 67.20 0.0018
2021-05-13 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 25,755 -10,655 -29.26 1,805 -17.16 0.0012
2021-02-11 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 36,410 5,412 17.46 2,179 16.90 0.0013
2020-11-12 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 30,998 -15,545 -33.40 1,864 -23.70 0.0012
2020-08-12 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 46,543 14,980 47.46 2,443 130.91 0.0019
2020-05-12 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 31,563 -8,680 -21.57 1,058 -41.96 0.0010
2020-02-12 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 40,243 8,330 26.10 1,823 50.04 0.0013
2019-11-08 2019-09-30 13F PACIRA BIOSCIENCES COM 695127100 31,913 -8,942 -21.89 1,215 -31.63 0.0010
2019-08-12 2019-06-30 13F PACIRA BIOSCIENCES COM 695127100 40,855 8,191 25.08 1,777 42.96 0.0014
2019-05-13 2019-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 32,664 -16,404 -33.43 1,243 -41.09 0.0012
2019-02-12 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 49,068 -4,348 -8.14 2,110 -19.65 0.0021
2018-11-13 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 53,416 16,455 44.52 2,626 121.60 0.0023
2018-08-10 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 36,961 -1,358 -3.54 1,185 -0.67 0.0011
2018-05-11 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 38,319 -6,437 -14.38 1,193 -41.58 0.0010
2018-02-12 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 44,756 -29,761 -39.94 2,042 -26.99 0.0016
2017-11-13 2017-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 74,517 -22,264 -23.00 2,797 -39.41 0.0023
2017-08-11 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 96,781 93,790 3,135.74 4,616 3,294.12 0.0042
2017-05-12 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 2,991 -10,623 -78.03 136 -69.09 0.0001
2017-02-10 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 13,614 -49,927 -78.57 440 -79.76 0.0004
2016-11-10 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 63,541 55,981 740.49 2,174 752.55 0.0020
2016-08-12 2016-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 7,560 -29,900 -79.82 255 -87.15 0.0003
2016-05-13 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 37,460 17,428 87.00 1,985 29.06 0.0022
2016-02-12 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 20,032 -9,465 -32.09 1,538 26.90 0.0015
2015-11-13 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 29,497 -2,667 -8.29 1,212 -46.70 0.0011
2015-08-13 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 32,164 400 1.26 2,274 -19.42 0.0020
2015-05-14 2015-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 31,764 11,091 53.65 2,822 53.87 0.0027
2015-02-17 2014-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 20,673 18,535 866.93 1,834 785.99 0.0016
2014-11-14 2014-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 2,138 292 15.82 207 21.76 0.0002
2014-08-14 2014-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 1,846 -5,749 -75.69 170 -67.98 0.0002
2014-05-15 2014-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 7,595 -6,314 -45.40 531 -33.54 0.0005
2014-02-14 2013-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 13,909 7,322 111.16 799 152.05 0.0007
2013-11-14 2013-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 6,587 5,998 1,018.34 317 1,661.11 0.0003
2013-08-14 2013-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 589 589 18 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-12 2020-06-30 13F PACIRA BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F PACIRA BIOSCIENCES COM Call 600 -66.67 20 -75.61 n/a n/a n/a
2020-02-12 2019-12-31 13F PACIRA BIOSCIENCES COM Call 1,800 -45.45 82 -34.92 n/a n/a n/a
2019-11-08 2019-09-30 13F PACIRA BIOSCIENCES COM Call 3,300 -66.67 126 -70.77 n/a n/a n/a
2019-08-12 2019-06-30 13F PACIRA BIOSCIENCES COM Call 9,900 800.00 431 926.19 n/a n/a n/a
2019-05-13 2019-03-31 13F PACIRA PHARMACEUTICALS COM Call 1,100 -26.67 42 -35.38 n/a n/a n/a
2019-02-12 2018-12-31 13F PACIRA PHARMACEUTICALS COM Call 1,500 -95.66 65 -96.18 n/a n/a n/a
2018-11-13 2018-09-30 13F PACIRA PHARMACEUTICALS COM Call 34,600 1,935.29 1,701 3,050.00 n/a n/a n/a
2018-08-10 2018-06-30 13F PACIRA PHARMACEUTICALS COM Call 1,700 -78.21 54 -77.78 n/a n/a n/a
2018-05-11 2018-03-31 13F PACIRA PHARMACEUTICALS COM Call 7,800 143.75 243 66.44 n/a n/a n/a
2018-02-12 2017-12-31 13F PACIRA PHARMACEUTICALS COM Call 3,200 433.33 146 534.78 n/a n/a n/a
2017-11-13 2017-09-30 13F PACIRA PHARMACEUTICALS COM Call 600 -90.77 23 -92.58 n/a n/a n/a
2017-08-11 2017-06-30 13F PACIRA PHARMACEUTICALS COM Call 6,500 -38.68 310 -35.82 n/a n/a n/a
2017-05-12 2017-03-31 13F PACIRA PHARMACEUTICALS COM Call 10,600 68.25 483 137.93 n/a n/a n/a
2017-02-10 2016-12-31 13F PACIRA PHARMACEUTICALS COM Call 6,300 -25.00 203 -29.27 n/a n/a n/a
2016-11-10 2016-09-30 13F PACIRA PHARMACEUTICALS COM Call 8,400 287 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-12 2020-06-30 13F PACIRA BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F PACIRA BIOSCIENCES COM Put 200 -95.00 7 -96.13 n/a n/a n/a
2020-02-12 2019-12-31 13F PACIRA BIOSCIENCES COM Put 4,000 -23.08 181 -8.59 n/a n/a n/a
2019-11-08 2019-09-30 13F PACIRA BIOSCIENCES COM Put 5,200 136.36 198 106.25 n/a n/a n/a
2019-08-12 2019-06-30 13F PACIRA BIOSCIENCES COM Put 2,200 120.00 96 152.63 n/a n/a n/a
2019-05-13 2019-03-31 13F PACIRA PHARMACEUTICALS COM Put 1,000 38 n/a n/a n/a
2019-02-12 2018-12-31 13F PACIRA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F PACIRA PHARMACEUTICALS COM Put 5,700 -50.86 280 -24.73 n/a n/a n/a
2018-08-10 2018-06-30 13F PACIRA PHARMACEUTICALS COM Put 11,600 -3.33 372 -0.53 n/a n/a n/a
2018-05-11 2018-03-31 13F PACIRA PHARMACEUTICALS COM Put 12,000 69.01 374 15.43 n/a n/a n/a
2018-02-12 2017-12-31 13F PACIRA PHARMACEUTICALS COM Put 7,100 162.96 324 220.79 n/a n/a n/a
2017-11-13 2017-09-30 13F PACIRA PHARMACEUTICALS COM Put 2,700 -22.86 101 -39.52 n/a n/a n/a
2017-08-11 2017-06-30 13F PACIRA PHARMACEUTICALS COM Put 3,500 118.75 167 128.77 n/a n/a n/a
2017-05-12 2017-03-31 13F PACIRA PHARMACEUTICALS COM Put 1,600 -36.00 73 -9.88 n/a n/a n/a
2017-02-10 2016-12-31 13F PACIRA PHARMACEUTICALS COM Put 2,500 -28.57 81 -32.50 n/a n/a n/a
2016-11-10 2016-09-30 13F PACIRA PHARMACEUTICALS COM Put 3,500 120 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.